Barrow Hanley Mewhinney & Strauss LLC Teva Pharmaceutical Industries LTD Transaction History

Barrow Hanley Mewhinney & Strauss LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$8.12 - $15.72 $23.9 Million - $46.3 Million	-2,942,539 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$15.58 - $20.01 $1.76 Million - $2.26 Million	112,888 Added 3.99%	2,942,539 $46.1 Million
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $717,579 - $1.17 Million	-49,183 Reduced 1.71%	2,829,651 $43.6 Million
Q3 2018 Nov 13, 2018	BUY	$21.06 - $25.65 $1 Million - $1.22 Million	47,700 Added 1.68%	2,878,834 $62 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $112,359 - $165,557	-6,700 Reduced 0.24%	2,831,134 $68.9 Million
Q1 2018 May 14, 2018	SELL	$16.68 - $22.07 $678,192 - $897,344	-40,659 Reduced 1.41%	2,837,834 $48.5 Million
Q4 2017 Feb 09, 2018	SELL	$11.23 - $19.1 $20.6 Million - $35.1 Million	-1,838,375 Reduced 38.97%	2,878,493 $54.5 Million
Q3 2017 Nov 13, 2017	BUY	$15.41 - $32.17 $72.7 Million - $152 Million	4,716,868	4,716,868 $83 Million

626

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Barrow Hanley Mewhinney & Strauss LLC, based on Form 13F filings with the SEC.

Stay updated on Barrow Hanley Mewhinney & Strauss LLC with notifications on news.